Key facts
- It has raised $27.1M across 3 recorded rounds; the latest was Early Stage VC ($7.6M) in Mar 2026.
- Notable investors include Matrix, Susa Ventures, Echo Health Ventures, HC9 Ventures.
- Optura has filed 2 Form Ds with the SEC, most recently Apr 2026 ($13.0M sold to 4 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Optura
Funding rounds
3 roundsAbout Optura
Developer of AI-driven enterprise software intended for improving operational efficiency and decision-making in healthcare organizations. The company's platform includes integrated intelligent systems for workflow automation, data analysis, and care optimization, enabling healthcare enterprises to reduce administrative burden, improve clinical outcomes, increase cost-efficiency, and support scalable transformation initiatives aligned with long-term value-based care models.
- Industry
- Enterprise Systems (Healthcare)
- Sector
- Healthcare
- HQ
- Franklin, TN, United States
- Founded
- 2024
- Employees
- 39
- Website
- optura.ai/
- Ownership
- Privately Held (backing)
Optura doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Optura shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Optura in its N-PORT filings yet. We sweep new filings monthly.